Impurity testing of ranitidine products: US FDA update

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1779卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71265-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1 / 1

相关论文

共 50 条

[21] US FDA requests HRT label update to reflect WHIMS findings
Reactions Weekly, 2004, 989 (1) : 2 - 2
[22] FDA implements safeguards to prevent contaminated products in US market
Reactions Weekly, 2023, 1948 (1) : 2 - 2
[23] No changes to Tysabri labelling, risk management plan - US FDA update
Reactions Weekly, 2009, 1271 (1) : 2 - 2
[24] US FDA recalls Hyland's belladonna teething products
Reactions Weekly, 2017, 1649 (1) : 5 - 5
[25] Marketing of unapproved drug products must stop - US FDA
Reactions Weekly, 2008, 1222 (1) : 4 - 4
[26] US FDA restricts use of opioid products for coughs/colds
Reactions Weekly, 2018, 1686 (1) : 9 - 9
[27] US FDA approves menthol e-cigarette products
Furlow, Bryant
LANCET RESPIRATORY MEDICINE, 2024, 12 (09): : 667 - 667
[28] US FDA removes boxed warning from canagliflozin products
Reactions Weekly, 2020, 1820 (1) : 5 - 5
[29] US FDA requires pancreatic insufficiency products to gain approval
Reactions Weekly, 2004, 1000 (1) : 3 - 3
[30] US FDA advises against use of Zicam cold products
Reactions Weekly, 2009, 1257 (1) : 3 - 3

← 1 2 3 4 5 →